Gaab M R, Czech T, Korn A
Br J Clin Pharmacol. 1985;20 Suppl 1(Suppl 1):67S-74S. doi: 10.1111/j.1365-2125.1985.tb05145.x.
Preliminary investigations indicated that the calcium antagonist nicardipine improved cerebral vascular circulation and cerebral metabolism. Therefore we examined the effect of nicardipine on the cerebral vessels, cerebral oxygen tension, and intracranial pressure (ICP) in patients with cerebrovascular disturbances. In patients with previous minor stroke undergoing surgery for extra-intracranial anastomosis, we applied nicardipine topically to the operation site by means of a perfusor and measured the diameter of the cerebral vessels. After several minutes, the topically applied nicardipine produced marked dilatation in the small arterial cortical vessels and relaxation of vasospasm. In the two patients studied so far, we observed a rapid increase in the cerebral PO2, which remained elevated after the initial peak as long as the infusion continued. With a lower dose the increase in the intracranial pulse amplitude (PAICP) was antagonized by the considerable drop in blood pressure which occurred after 10 mg h-1 nicardipine. The results indicate that nicardipine dilates the cerebral vessels and increases the cerebral oxygen tension.
初步研究表明,钙拮抗剂尼卡地平可改善脑血管循环和脑代谢。因此,我们研究了尼卡地平对脑血管疾病患者脑血管、脑氧分压和颅内压(ICP)的影响。在既往有轻微中风且正在接受颅外吻合手术的患者中,我们通过灌注器将尼卡地平局部应用于手术部位,并测量脑血管直径。几分钟后,局部应用的尼卡地平使大脑皮质小动脉血管显著扩张,并缓解了血管痉挛。在目前研究的两名患者中,我们观察到脑PO2迅速升高,只要持续输注,在最初的峰值后仍保持升高。使用较低剂量时,颅内脉搏振幅(PAICP)的增加被尼卡地平10 mg/h后出现的血压显著下降所拮抗。结果表明,尼卡地平可扩张脑血管并增加脑氧分压。